Title Physician

ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) (ACTION)

NCT ID : 05580562
Protocol Number : ONC201-108
Phase : 3
Location : Saint John's Cancer Institute
 Akanksha Sharma, M.D.

Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab (IORT)

NCT ID : 04681677
Protocol Number : CTPR-0017 GLIOX
Phase : 2
Location : Santa Monica, Ca
 Naveed Wagle, M.D.

(TRIDENT) Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With Radiation Therapy Temozolomide for the Treatment of Newly Diagnosed GBM (EF-32)

NCT ID : 04471844
Protocol Number : EF-32 Trident
Phase : 3
Location : Saint John's Cancer Institute
 Akanksha Sharma, M.D.

A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme (WHO Grade IV)

NCT ID : 04762069
Protocol Number : CNS-201
Phase : 2
Location : Saint John's Cancer Institute
Naveed Wagle, M.D.

Intermediate-size Expanded Access to ONC201 for Patients with H3 K27M-mutant and/or Midline Gliomas

NCT ID : 04617002
Protocol Number : ONC028
Phase : N/A
Location : Santa Monica, CA
 Akanksha Sharma, M.D.

Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients With Recurrent High-Grade Glioma

NCT ID : 04388475
Protocol Number : OKN-007-OL
Phase : 1
Location : Saint John's Cancer Institute
 Naveed Wagle, M.D.

Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations (FIGHT-209)

NCT ID : 05267106
Protocol Number : INCB 54828-209
Phase : 2
Location : Santa Monica, CA
 Akanksha Sharma, M.D.